|Articles|December 1, 2002

Patient-Reported Outcomes and Managed Care Decisions: Quality of Life and Related Components
Volume 8
Issue 18 Suppl

An Introduction to Quality-of-Life Assessment in Oncology: The Value of Measuring Patient-Reported Outcomes

Author(s)Carolyn E. Schwartz, ScD, Mirjam A.G. Sprangers, PhD

Download PDF: An Introduction to Quality-of-Life Assessment in Oncology: The Value of Measuring Patient-Reported Outcomes

Articles in this issue

over 23 years ago

Article

Participating Faculty

over 23 years ago

Article

Patient-Reported Outcomes and Managed Care Decisions: Quality of Life and Related Components

over 23 years ago

Article

Quality of Life and Symptom Measures in Oncology: An Overview

over 23 years ago

Article

Quality-of-Life Measurements: A Soft Outcome - Or is it?

over 23 years ago

Article

The Role of Patient-Reported Outcomes in Evaluating the Quality of Oncology Care

over 23 years ago

Article

Continuing Medical Education Quiz

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

An Introduction to Quality-of-Life Assessment in Oncology: The Value of Measuring Patient-Reported Outcomes

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

Jeff Hunnicutt to Bring Community Oncology Roots to New Role as Navista COO

Contributor: State Leaders Need Real-World Evidence to Integrate Social Care at Scale

Nipocalimab Improves gMG Outcomes Across East Asian Subgroup

New MINT Trial Analysis Favors Liberal Transfusion After MI

Diagnosing Alzheimer's Disease Agitation: Triggers, Care Specialties, and the Role of Primary Care